S80559 |
Difluprednate |
源葉(MedMol) | 98% |
品牌 | 貨號 | 產(chǎn)品規(guī)格 | 價格(RMB) | 庫存(上海) | 北京 | 武漢 | 南京 | 數(shù)量 | 計(jì)量單位 | 加入購物車... |
---|---|---|---|---|---|---|---|---|---|---|
源葉(MedMol) | S80559-50mg | 98% | ¥200.00元 | 6 | - | - | - | EA | 加入購物車 | |
源葉(MedMol) | S80559-100mg | 98% | ¥350.00元 | 6 | - | - | - | EA | 加入購物車 | |
源葉(MedMol) | S80559-500mg | 98% | ¥1600.00元 | 3 | - | - | - | EA | 加入購物車 |
- 提示:詳情請下載說明書。
- 產(chǎn)品描述: Difluprednate(Durezol) is a corticosteroid, approved for the treatment of post-operative ocular inflammation and pain.
- 體內(nèi)研究:
Difluprednate emulsion is rapidly deacetylated in the aqueous humor to difluoroprednisolone butyrate (DFB) in rats and rabbits, the drug's active metabolite, which has a similar corticosteroid activity profile. Radio-labeled difluprednate is instilled in the right eyes of pigmented rabbits in a separate study examining DFBA excretion. Difluprednate (0.05% emulsion) results in higher aqueous humor concentrations than the suspension form in the eyes of rabbits. Difluprednate concentrations ≥0.01% shows a statistically significant inhibition of inflammation compared to saline in a rabbit model, with the anti-inflammatory response proceeding in a dose-dependent manner. Difluprednate suppresses uveitis in all three concentration (0.002%, 0.01%, and 0.05%) in a dose-dependent manner in rats, and difluprednate 0.05% shows statistically superior anti-inflammatory activity compared to Betamethasone (0.1%).
- 參考文獻(xiàn):
1. Donnenfeld ED, et al. Clin Ophthalmol, 2011, 5, 811-816. 2.Jamal KN, et al. Clin Ophthalmol, 2009, 3, 381-390.
- 溶解性: Soluble in DMSO、Ethanol
- 保存條件: 2-8℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 1.966 ml 9.832 ml 19.664 ml 5 mM 0.393 ml 1.966 ml 3.933 ml 10 mM 0.197 ml 0.983 ml 1.966 ml 50 mM 0.039 ml 0.197 ml 0.393 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:
本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)
=**